Posts

11 September 2020, London: The GSMA has been organising the industry’s premier mobile events since 2006. During that time, we’ve responded to various emergent situations and are now closely monitoring the changing global circumstances around Covid-19. The GSMA’s approach is safety first, and we are working to ensure that MWC21 proceeds in the safest way for all participants. 

GSMA Guidelines on Health and Safety for MWC21

As always, health and safety are a paramount consideration, and we are working closely with Fira Barcelona and the Host City Parties in Spain to ensure we incorporate all guidance and provide the best level of protection possible at the event. Whilst many safety standards will be mandated; our approach is to meet and then surpass those standards where possible. Our planning principles include;

  • Collaboration: Our dialogue with key partners and exhibitors is in full force to ensure a safe build-up and operation of MWC incorporating all emerging guidance
  • Partnership: The GSMA works directly with the Spanish and Catalan governments, the Host City Parties and Fira de Barcelona to ensure a safe and healthy experience for all involved in the event. This partnership will build on the Protocol on Safety and Prevention against COVID-19 currently being implemented by Fira de Barcelona
  • Expert advice and health and safety measures: We are defining strict standards and best practice with direction from health authorities around the world including, the WHO, scientific research, health and safety experts and Spanish and Catalan health authorities

Updates on our enhanced health and safety measures and our ‘touchless’ environment will be available in the coming weeks. Some of the health & safety measures and protocols exhibitors and attendees will be obliged to follow include;

  • Social distancing and traffic flows
  • We will optimise the exhibition layout to improve flow and support social distancing through real-time data sharing and analysis
    • The venue will be set up to ensure the 1.5m distance guidelines are met
    • All spaces will be designed to ensure a crowd density of no less than 2.5m2 per person can be maintained
    • Exhibitors will be required to adhere to strict stand capacity and flow requirements as well as stand design adjustments
  • Personal protective equipment
  • Protective face masks will be mandatory
  • Hygiene
    • The environment will minimise touch, with entry, information points and registration all becoming touchless
    • Hand sanitiser will be widely available throughout the venue and required at each Exhibitor stand
    • There will be enhanced cleaning measures throughout the venue, with particular attention paid to high contact surfaces
    • Exhibitors will be obliged to conduct frequent cleaning and disinfection of their stands
    • Where the handling of products or other materials is necessary, it will be essential for items and hands to be sanitised before and after use with an approved hydro-alcoholic sanitising solution
    • Specific cleaning and sterilisation regimes will be in place for any audio-visual equipment
  • Training
    • Exhibitors must ensure that all staff and contractors have received, as a minimum, training in the health and safety guidelines and rules provided

The GSMA will abide by every step outlined in our health and safety guidelines and will enforce compliance throughout the event to ensure that exhibitors and attendees also comply.

Apple is working with COPAN Diagnostics to rapidly expand production of collection kits that are critical for COVID-19 testing.
Cupertino, California — Apple today announced it is awarding $10 million from its Advanced Manufacturing Fund to COPAN Diagnostics, a market leader in sample collection kits that play a critical role in COVID-19 testing. This funding will allow COPAN Diagnostics to rapidly accelerate their supply of sample collection kits for hospitals across the United States, expanding production from several thousand today to more than one million kits per week by early July. As part of this effort, Apple will support COPAN Diagnostics’ expansion to a new, larger facility in Southern California, with advanced equipment that Apple is helping design. This expansion is expected to create more than 50 new jobs.

Apple awards $10 million from Advanced Manufacturing Fund to COPAN Diagnostics

“We feel a deep sense of responsibility to do everything we can to help medical workers, patients, and communities support the global response to COVID-19,” said Jeff Williams, Apple’s chief operating officer. “COPAN is one of the world’s most innovative manufacturers of sample collection kits for COVID-19 testing, and we’re thrilled to partner with them so they can expand as we work to address this critical issue for our nation. I couldn’t be prouder of our teams for bringing all of their energy, passion, and innovative spirit to supporting the country’s COVID-19 response.”
“We’re excited to forge this new relationship with Apple, whose teams are already making a huge difference with our efforts to scale up the production of our sample collection and transport kits,” said Norman Sharples, CEO of COPAN Diagnostics. “Collection and transport kits are a critical component in the fight against COVID-19. At COPAN, we’re excited and grateful for this partnership with Apple as our strong beliefs of innovation, quality, and excellence in manufacturing and design are perfectly aligned. Apple’s operational expertise will help us increase delivery of important pre-analytical tools for medical professionals across the country at this critical time.”
COPAN’s sample collection kits have revolutionized the diagnostics industry and play a critical role in the COVID-19 testing process.
Apple is sourcing equipment and materials for COPAN Diagnostics from companies across the US, including equipment Apple is helping design from K2 Kinetics, based in York, Pennsylvania, and MWES in Waukesha, Wisconsin.
COPAN is a global player in the field of specimen collection and preservation for infectious disease diagnostics. The company’s sample collection kits have revolutionized the diagnostic industry and play a critical role in the COVID-19 testing process. The company’s unique quantitative approach to pre-analytics led them to invent flocked swabs in 2003, a revolutionary device comprising of a molded plastic applicator stick that has variable tips coated with Nylon fibers allowing for quick uptake and complete elution of the sample. COPAN’s UTM is the leading transport medium for collection, transport, preservation, and long-term freeze storage of clinical specimens containing viruses.
Apple’s financial and operational support will help COPAN increase supply to more than one million kits per week by early July.

Apple’s Support for the Worldwide Response to COVID-19

Apple has donated tens of millions of dollars toward the global COVID-19 response, including Global Citizen and America’s Food Fund. In addition, Apple designed, tested, and distributed almost 10 million face shields and sourced over 30 million face masks for healthcare professionals in hard-hit areas. Apple also developed a COVID-19 symptom-checking website and app in partnership with the CDC, and announced a collaboration with Google to develop COVID-19 contact tracing technology to help governments and health agencies reduce the spread of the virus, with user privacy and security central to the design.
Apple’s impact also extends to its range of innovative services. Apple News is connecting users with trusted information from reliable sources with its dedicated COVID-19 section, and Apple has worked with everyone from Oprah to Lady Gaga to help customers find information, entertainment, and ways to contribute to charitable causes through Apple TV.
Apple’s contributions to COVID-19 relief efforts include screening tools along with vital PPE and financial donations.

Apple in the United States

Apple is on track to reach its commitment of contributing $350 billion to the US economy over a five year period. The company supports 2.4 million jobs across the US, including 90,000 direct employees in all 50 states.
Apple has already invested more than $1 billion of its $5 billion Advanced Manufacturing Fund in American companies fostering innovation and growth in the US manufacturing sector. That includes $450 million distributed to Corning Incorporated in Harrodsburg, Kentucky, to support its research and development into state-of-the-art glass processes, equipment, and materials integral to the delivery of next-generation consumer devices; $390 million to Finisar in Sherman, Texas, to increase its R&D spending and high-volume production of vertical-cavity surface-emitting lasers; and $10 million allocated to the Elysis aluminum partnership to bring revolutionary advancements in green aluminum manufacturing to the commercial market.